Average Co-Inventor Count = 4.91
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xencor, Inc. (54 from 216 patents)
2. Genentech, Inc. (1 from 3,212 patents)
3. Amgen Inc. (1,960 patents)
54 patents:
1. 12448423 - Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
2. 12415849 - Heterodimeric proteins
3. 12359002 - Heterodimeric antibodies that bind CD3 and tumor antigens
4. 12239688 - IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof
5. 12234270 - IL-12 heterodimeric Fc-fusion proteins
6. 12129309 - Heterodimeric antibodies that bind CD3 and CD38
7. 12054545 - Heterodimeric antibodies that bind somatostatin receptor 2
8. 12006345 - Untargeted and targeted IL-10 Fc-fusion proteins
9. 11981717 - Engineered IL-2 Fc fusion proteins
10. 11945880 - Heterodimeric antibodies that bind CD3 and tumor antigens
11. 11932675 - PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties
12. 11859011 - Heterodimeric antibodies that bind CD3 and tumor antigens
13. 11851466 - Targeted IL-12 heterodimeric Fc-fusion proteins
14. 11814423 - Heterodimeric proteins
15. 11718667 - Optimized antibody variable regions